Cohort (CHRT)

Sector:

Defense and Aeronautics

Index:

FTSE AIM All-Share

1,000.00p
   
  • Change Today:
      86.00p
  • 52 Week High: 1,000.00p
  • 52 Week Low: 490.00p
  • Currency: UK Pounds
  • Shares Issued: 41.87m
  • Volume: 618,915
  • Market Cap: £418.66m
  • RiskGrade: 133
  • Beta: 0.10

Cohort subsidiary receives two orders from MOD

By Iain Gilbert

Date: Friday 01 Apr 2022

LONDON (ShareCast) - (Sharecast News) - Technology firm Cohort has received two orders from the UK Ministry of Defence for its long-term partner INVISIO's hearing protection and communication ancillaries, for use on armoured fighting vehicles and in dismounted close combat.
Cohort said on Friday that the first order, secured by its Marlborough Communications subsidiary, was valued at over £9.0m and was for the INVISIO V-Series Gen II platform for use on armoured fighting vehicles, while the second order was for further deliveries of INVISIO's Tactical Hearing Protection System Dismounted Close Combat Users program.

The AIM-listed firm added that deliveries were set to commence in the second half of 2022 through to mid-2023.

Chief executive Andy Thomis said: "These orders are a clear demonstration of the strength of the 10-year partnership and collaboration between MCL and INVISIO, and further cement MCL's position as the MOD's leading supplier of innovative hearing protection systems, to protect UK military personnel.

"Together with other recent contract wins across the group, these orders further strengthen our order book and enhance the visibility of future revenues."

As of 0925 BST, Cohort shares were up 0.25% to 455.15p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cohort Market Data

Currency UK Pounds
Share Price 1,000.00p
Change Today 86.00p
% Change 9.41 %
52 Week High 1,000.00p
52 Week Low 490.00p
Volume 618,915
Shares Issued 41.87m
Market Cap £418.66m
Beta 0.10
RiskGrade 133

Cohort Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.35% below the market average84.35% below the market average84.35% below the market average84.35% below the market average84.35% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Income
53.72% below the market average53.72% below the market average53.72% below the market average53.72% below the market average53.72% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Growth
58.66% above the market average58.66% above the market average58.66% above the market average58.66% above the market average58.66% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cohort Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Aug-24 04-Jan-24
Paid 02-Oct-24 13-Feb-24
Amount 10.10p 4.70p

Trades for 21-Nov-2024

Time Volume / Share Price
15:30 10,000 @ 980.00p
16:28 3,000 @ 985.00p
12:34 56,800 @ 960.00p
11:54 17,989 @ 951.21p
12:49 12,000 @ 965.00p

Cohort Key Personnel

Chair Nicholas Martin Prest
CEO Andrew Stephen Thomis
Finance Director Simon Walther

Top of Page